ZONISAMIDE NEURAXPHARM 25 MG TBL NOB 28

What is the maximum co-payment for ZONISAMIDE NEURAXPHARM?

If the insurance company contributes, the maximum co-payment is 0,00 Kč. The maximum pharmacy price is 229,70 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, zkontrolujte ale specializaci předepisujího lékaře níže.

Does ZONISAMIDE NEURAXPHARM have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

229,71 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Přídatná léčba epilepsie je hrazena u dospělých a dětí od 6 let věku s parciálními záchvaty s nebo bez sekundární generalizace, splňující nejméně jedno z následujících kritérií: 1) nedostatečná terapeutická odpověď nebo intolerance antiepileptik první volby 2) vysoké riziko nežádoucích účinků nebo kontraindikace použití antiepileptik první volby.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe ZONISAMIDE NEURAXPHARM?

psychiatry, child and adolescent psychiatry, geriatric psychiatry
neurology, pediatric neurology

What is the composition of ZONISAMIDE NEURAXPHARM?

Zonisamid (25 mg), neznámá látka s kódem 3755, monohydrát laktosy, sodná sůl kroskarmelosy, povidon k 25, natrium-lauryl-sulfát, koloidní bezvodý oxid křemičitý, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to ZONISAMIDE NEURAXPHARM?

The medicine belongs to ATC group N03AX15 – ZONISAMID. Medicines with the same active substance can be found here.

Who manufactures ZONISAMIDE NEURAXPHARM?

Neuraxpharm Bohemia s.r.o., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 20. 1. 2026. Production was terminated with effect from 21. 3. 2026. The manufacturer lists medicines with the following code as a potential substitute:

Note provided: Lék v jiné síle – 50 mg (tablets lze dělit).